Back to Search
Start Over
Switzerland : Novartis reports landmark Phase III results for AIN457 (secukinumab) showing rapid and significant efficacy in psoriatic arthritis patients
- Source :
- Mena Report. November 18, 2014
- Publication Year :
- 2014
-
Abstract
- Novartis announced today first ever results from the pivotal Phase III FUTURE 1 and FUTURE 2 studies showing AIN457 (secukinumab) demonstrated rapid and significant clinical improvements versus placebo in improving [...]
Details
- Language :
- English
- ISSN :
- 22190112
- Database :
- Gale General OneFile
- Journal :
- Mena Report
- Publication Type :
- News
- Accession number :
- edsgcl.390583747